InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

- Current share price for NSB : $0.063

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Strategic Placement to AlphaSwiss Partners 11 Nov 2020 2:29PM $0.300 $0.063 fallen by 79%
$25 Trading Halt 9 Nov 2020 9:37AM $0.300 $0.063 fallen by 79%
$25 Letter to Shareholders - Notice of Meeting/Proxy form 30 Oct 2020 4:57PM $0.280 $0.063 fallen by 77.50%
$25 Notice of Annual General Meeting/Proxy Form 30 Oct 2020 4:55PM $0.280 $0.063 fallen by 77.50%
$25 Appendix 4C - quarterly 30 Oct 2020 12:11PM $0.290 $0.063 fallen by 78.28%
$25 AusBiotech Invest 2020 Conference Presentation 28 Oct 2020 8:17AM $0.295 $0.063 fallen by 78.64%
$25 Appendix 2A 13 Oct 2020 8:01AM $0.335 $0.063 fallen by 81.19%
$25 BIO Investor Forum Presentation 13 Oct 2020 8:00AM $0.335 $0.063 fallen by 81.19%
$25 Appendix 2A 30 Sep 2020 7:23PM $0.265 $0.063 fallen by 76.23%
$25 Details of Company Address 25 Sep 2020 5:14PM $0.280 $0.063 fallen by 77.50%
$25 R&D Tax Rebate Received 25 Sep 2020 10:17AM $0.270 $0.063 fallen by 76.67%
$25 Expiry of performance shares 1 Sep 2020 6:15PM $0.250 $0.063 fallen by 74.80%
$25 Appendix 2A Amendment 1 Sep 2020 6:14PM $0.250 $0.063 fallen by 74.80%
$25 Appendix 4E and Annual Report 28 Aug 2020 5:13PM $0.235 $0.063 fallen by 73.19%
$25 Appendix 2A 27 Aug 2020 6:58PM $0.230 $0.063 fallen by 72.61%
$25 Westar Capital Investor Presentation 26 Aug 2020 8:07AM $0.240 $0.063 fallen by 73.75%
$25 Updated Appendix 4C 12 Aug 2020 8:20AM $0.220 $0.063 fallen by 71.36%
$25 Full Report from Multiple Sclerosis Study 4 Aug 2020 9:25AM $0.240 $0.063 fallen by 73.75%
$25 Change in substantial holding 31 Jul 2020 11:53AM $0.220 $0.063 fallen by 71.36%
$25 Appendix 3Y 31 Jul 2020 11:53AM $0.220 $0.063 fallen by 71.36%
$25 Appendix 3Y 31 Jul 2020 11:53AM $0.220 $0.063 fallen by 71.36%
$25 Appendix 3Y 31 Jul 2020 11:52AM $0.220 $0.063 fallen by 71.36%
$25 Appendix 2A 31 Jul 2020 11:50AM $0.220 $0.063 fallen by 71.36%
$25 Appendix 4C - quarterly 31 Jul 2020 11:35AM $0.225 $0.063 fallen by 72%
$25 Professor Dao-Yi Yu appointed to Scientific Advisory Board 30 Jul 2020 8:09AM $0.215 $0.063 fallen by 70.70%

276 - 300 of 407 results

Page 12 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.